Atlas Trials

Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection

Clinical trial NCT03124199 · COMPLETED

Trial details

NCT number
NCT03124199
Sponsor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Start date
2014-02-01
Primary completion
2015-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.